标题
Breast cancer liver metastasis: current and future treatment approaches
作者
关键词
-
出版物
CLINICAL & EXPERIMENTAL METASTASIS
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-03-06
DOI
10.1007/s10585-021-10080-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Transcriptional diversity and bioenergetic shift in human breast cancer metastasis revealed by single-cell RNA sequencing
- (2020) Ryan T. Davis et al. NATURE CELL BIOLOGY
- Nano Codelivery of Oxaliplatin and Folinic Acid Achieves Synergistic Chemo-Immunotherapy with 5-Fluorouracil for Colorectal Cancer and Liver Metastasis
- (2020) Jianfeng Guo et al. ACS Nano
- NK1R antagonist decreases inflammation and metastasis of breast carcinoma cells metastasized to liver but not to brain; phenotype-dependent therapeutic and toxic consequences
- (2020) Esra Nizam et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Epidemiology of liver metastases
- (2020) Samantha R Horn et al. Cancer Epidemiology
- Reactivation of BMP signaling by suboptimal concentrations of MEK inhibitor and FK506 reduces organ-specific breast cancer metastasis
- (2020) Jiang Ren et al. CANCER LETTERS
- A Phase Ib study of alpelisib or buparlisib combined with tamoxifen plus goserelin in premenopausal women with HR-positive HER2-negative advanced breast cancer
- (2020) Yen-Shen Lu et al. CLINICAL CANCER RESEARCH
- Proteomic and transcriptomic profiling identifies mediators of anchorage-independent growth and roles of inhibitor of differentiation proteins in invasive lobular carcinoma
- (2020) Nilgun Tasdemir et al. Scientific Reports
- Early Death Incidence and Prediction in Stage IV Breast Cancer
- (2020) Yumei Zhao et al. MEDICAL SCIENCE MONITOR
- Efficacy and Safety of Cyclin-Dependent Kinases 4 and 6 Inhibitors in HR+/HER2− Advanced Breast Cancer
- (2020) Ning Xie et al. Cancer Management and Research
- Characterizations of Cancer Gene Mutations in Chinese Metastatic Breast Cancer Patients
- (2020) Zhonghua Tao et al. Frontiers in Oncology
- FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic disease
- (2020) Susana Garcia-Recio et al. JOURNAL OF CLINICAL INVESTIGATION
- Comparative effectiveness of trastuzumab emtansine versus lapatinib plus capecitabine for HER2+ metastatic breast cancer
- (2020) Sreeram V Ramagopalan et al. Journal of Comparative Effectiveness Research
- Breast Subtypes and Prognosis of Breast Cancer Patients With Initial Bone Metastasis: A Population-Based Study
- (2020) Deyue Liu et al. Frontiers in Oncology
- ER+/HER2+ Breast Cancer Has Different Metastatic Patterns and Better Survival Than ER−/HER2+ Breast Cancer
- (2019) Cletus A. Arciero et al. Clinical Breast Cancer
- Efficacy and Safety of Ribociclib Plus Letrozole in US Patients Enrolled in the MONALEESA-2 Study
- (2019) Denise A. Yardley et al. Clinical Breast Cancer
- OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician’s choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer
- (2019) M E Robson et al. ANNALS OF ONCOLOGY
- Quantitative assessment of breast cancer liver metastasis expansion with patient-derived xenografts
- (2019) Mohammad A. Alzubi et al. CLINICAL & EXPERIMENTAL METASTASIS
- Alpelisib for PIK3CA-Mutated, Hormone Receptor–Positive Advanced Breast Cancer
- (2019) Fabrice André et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of palbociclib plus endocrine therapy in North American women with hormone receptor‐positive/human epidermal growth factor receptor 2‐negative metastatic breast cancer
- (2019) Karen A. Gelmon et al. Breast Journal
- Identification of Alternatively-Activated Pathways between Primary Breast Cancer and Liver Metastatic Cancer Using Microarray Data
- (2019) Wang et al. Genes
- Local Treatment of Breast Cancer Liver Metastasis
- (2019) Reto Bale et al. Cancers
- Breast cancer statistics, 2019
- (2019) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Inflammation induced by incomplete radiofrequency ablation accelerates tumor progression and hinders PD-1 immunotherapy
- (2019) Liangrong Shi et al. Nature Communications
- Liver-dominant Breast Cancer Metastasis: A Comparative Outcomes Study of Chemoembolization Versus Radioembolization
- (2018) ANTICANCER RESEARCH
- Combined drug therapeutic strategies for the effective treatment of Triple Negative Breast Cancer
- (2018) Naveen K.R. Chalakur-Ramireddy et al. BIOSCIENCE REPORTS
- Surgical resection versus systemic therapy for breast cancer liver metastases: Results of a European case matched comparison
- (2018) A. Ruiz et al. EUROPEAN JOURNAL OF CANCER
- The role of liver resection in patients with metastatic breast cancer: a systematic review examining the survival impact
- (2018) Sadia Tasleem et al. IRISH JOURNAL OF MEDICAL SCIENCE
- Using patient-derived xenograft models of colorectal liver metastases to predict chemosensitivity
- (2018) Kai M. Brown et al. JOURNAL OF SURGICAL RESEARCH
- Targeting STAT3 to Suppress Systemic Pro-Oncogenic Effects from Hepatic Radiofrequency Ablation
- (2018) Gaurav Kumar et al. RADIOLOGY
- Radiofrequency ablation versus hepatic resection for breast cancer liver metastasis: a systematic review and meta-analysis
- (2018) Yi-bin Xiao et al. Journal of Zhejiang University-SCIENCE B
- Incidence and prognostic factors of patients with synchronous liver metastases upon initial diagnosis of breast cancer: a population-based study
- (2018) Hai-yun Zhao et al. Cancer Management and Research
- Capecitabine in early breast cancer: A meta-analysis of randomised controlled trials
- (2017) Akina Natori et al. EUROPEAN JOURNAL OF CANCER
- Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial
- (2017) Véronique Diéras et al. LANCET ONCOLOGY
- Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study
- (2017) Yue Gong et al. Scientific Reports
- Hepatic Resection or Ablation for Isolated Breast Cancer Liver Metastasis
- (2016) Eran Sadot et al. ANNALS OF SURGERY
- Biological Subtypes and Distant Relapse Pattern in Breast Cancer Patients After Curative Surgery (Study of Anatolian Society of Medical Oncology)
- (2016) Muhammet A. Kaplan et al. Breast Care
- Yttrium-90 hepatic radioembolization: clinical review and current techniques in interventional radiology and personalized dosimetry
- (2016) Aaron K T Tong et al. BRITISH JOURNAL OF RADIOLOGY
- Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models
- (2016) Victoria L Bridgeman et al. JOURNAL OF PATHOLOGY
- Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial
- (2016) John F R Robertson et al. LANCET
- Identification of liver metastases with probe-based confocal laser endomicroscopy at two excitation wavelengths
- (2016) Crispin Schneider et al. LASERS IN SURGERY AND MEDICINE
- Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases
- (2016) Sophia Frentzas et al. NATURE MEDICINE
- A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
- (2016) Erica T. Goddard et al. Jove-Journal of Visualized Experiments
- SOLTI NeoPARP: a phase II randomized study of two schedules of iniparib plus paclitaxel versus paclitaxel alone as neoadjuvant therapy in patients with triple-negative breast cancer
- (2015) Antonio Llombart-Cussac et al. BREAST CANCER RESEARCH AND TREATMENT
- Breast cancer statistics, 2015: Convergence of incidence rates between black and white women
- (2015) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Mechanisms involved in breast cancer liver metastasis
- (2015) Rui Ma et al. Journal of Translational Medicine
- A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis
- (2015) Elvin Wagenblast et al. NATURE
- Phase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancer
- (2014) Jasmeet Chadha Singh et al. BREAST CANCER RESEARCH
- Phase III Study of Iniparib Plus Gemcitabine and Carboplatin Versus Gemcitabine and Carboplatin in Patients With Metastatic Triple-Negative Breast Cancer
- (2014) Joyce O'Shaughnessy et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment of HER2-positive breast cancer
- (2013) Maria Cristina Figueroa-Magalhães et al. BREAST
- A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models
- (2013) X. Zhang et al. CANCER RESEARCH
- Liver metastases from breast cancer: Surgical resection or not? A case-matched control study in highly selected patients
- (2013) P. Mariani et al. EJSO
- Metastatic progression of breast cancer: insights from 50 years of autopsies
- (2013) Margaret C Cummings et al. JOURNAL OF PATHOLOGY
- Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial
- (2013) Stephen RD Johnston et al. LANCET ONCOLOGY
- Progression of Ocular Melanoma Metastasis to the Liver
- (2013) Hans E. Grossniklaus JAMA Ophthalmology
- Radiofrequency Ablation of Liver Tumors
- (2013) Debra Gervais et al. SEMINARS IN INTERVENTIONAL RADIOLOGY
- Fulvestrant 500 mg versus anastrozole 1 mg for the first-line treatment of advanced breast cancer: follow-up analysis from the randomized ‘FIRST’ study
- (2012) John F. R. Robertson et al. BREAST CANCER RESEARCH AND TREATMENT
- The histological growth pattern of colorectal cancer liver metastases has prognostic value
- (2012) Gert G. Van den Eynden et al. CLINICAL & EXPERIMENTAL METASTASIS
- FACT: An Open-Label Randomized Phase III Study of Fulvestrant and Anastrozole in Combination Compared With Anastrozole Alone As First-Line Therapy for Patients With Receptor-Positive Postmenopausal Breast Cancer
- (2012) Jonas Bergh et al. JOURNAL OF CLINICAL ONCOLOGY
- Combination Anastrozole and Fulvestrant in Metastatic Breast Cancer
- (2012) Rita S. Mehta et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse
- (2011) J. Chuck Harrell et al. BREAST CANCER RESEARCH AND TREATMENT
- Organotropism and prognostic marker discordance in distant metastases of breast carcinoma: fact or fiction? A clinicopathologic analysis
- (2011) Paul St. Romain et al. HUMAN PATHOLOGY
- The seed and soil hypothesis revisited-The role of tumor-stroma interactions in metastasis to different organs
- (2011) Robert R. Langley et al. INTERNATIONAL JOURNAL OF CANCER
- Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance
- (2011) J.-P. Gillet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Resection of liver metastases from breast cancer: Towards a management guideline
- (2011) Mohammad Howlader et al. International Journal of Surgery
- Metastatic Behavior of Breast Cancer Subtypes
- (2010) Hagen Kennecke et al. JOURNAL OF CLINICAL ONCOLOGY
- Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study
- (2009) Bella Kaufman et al. JOURNAL OF CLINICAL ONCOLOGY
- Hepatic complications of breast cancer
- (2009) Jennifer R Diamond et al. LANCET ONCOLOGY
- Breast Cancer Liver Metastases: US-guided Percutaneous Radiofrequency Ablation—Intermediate and Long-term Survival Rates
- (2009) Maria Franca Meloni et al. RADIOLOGY
- Dangerous halo after neoadjuvant chemotherapy and two-step hepatectomy for colorectal liver metastases
- (2008) G. Mentha et al. BRITISH JOURNAL OF SURGERY
- Subtypes of Breast Cancer Show Preferential Site of Relapse
- (2008) M. Smid et al. CANCER RESEARCH
- Two distinct expression patterns of urokinase, urokinase receptor and plasminogen activator inhibitor-1 in colon cancer liver metastases
- (2008) Martin Illemann et al. INTERNATIONAL JOURNAL OF CANCER
- Phase III Study Comparing Exemestane With Tamoxifen As First-Line Hormonal Treatment of Metastatic Breast Cancer in Postmenopausal Women: The European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative Group
- (2008) Robert J. Paridaens et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started